Spironolactone Does Not Prevent Acute Mountain Sickness: A Prospective, Double- Blind, Randomized, Placebo-Controlled Trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group) Buddha Basnyat, MD, MSc, FACP, FRCP (E), Peter S. Holck, PhD, Matiram Pun, MBBS, Stephen Halverson, MD, Piotr Szawarski, MD, Jeffrey Gertsch, MD, Mike Steif, EMT, Skip Powell, MD, Subhash Khanal, MBBS, Anip Joshi, MBBS, Ravi Shankar, Jamie Karambay, MS, Hattie D. Alexander, MD, Allyson Stone, MS, Candice Morrissey, MSPH, Beth H. Thompson, MD, Jeremy Farrar, BSc, MBBS, FRCP, DPhil, OBE Wilderness & Environmental Medicine Volume 22, Issue 1, Pages 15-22 (March 2011) DOI: 10.1016/j.wem.2010.10.009 Copyright © 2011 Wilderness Medical Society Terms and Conditions
Figure 1 Lobuje: study endpoint. Wilderness & Environmental Medicine 2011 22, 15-22DOI: (10.1016/j.wem.2010.10.009) Copyright © 2011 Wilderness Medical Society Terms and Conditions
Figure 2 Study flow chart. Wilderness & Environmental Medicine 2011 22, 15-22DOI: (10.1016/j.wem.2010.10.009) Copyright © 2011 Wilderness Medical Society Terms and Conditions